Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Early Cutaneous Manifestations of COVID-19: A Systematic Review and Public Health Implications.
WMJ. 2023 Dec;122(5):349-356.
WMJ. 2023.
PMID: 38180923
Free article.
RESULTS: Ninety-seven patients were included. Urticarial (24.7%) and maculopapular (22.7%) lesions were most common, followed by pernio (17.5%), vesicular (14.4%), papulosquamous (8.2%), and purpuric (5.1%) lesions. ...Although sample size is limited, all pur …
RESULTS: Ninety-seven patients were included. Urticarial (24.7%) and maculopapular (22.7%) lesions were most common, followed by pern …
A Systematic Review on the Treatment of Dermatosis Papulosa Nigra.
Maghfour J, Ogunleye T.
Maghfour J, et al.
J Drugs Dermatol. 2021 Apr 1;20(4):467-472. doi: 10.36849/JDD.2021.5555.
J Drugs Dermatol. 2021.
PMID: 33852246
While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large and multiple lesions in cosmetically sensitive areas may be emotionally and socially distressful to patients. ...
While prevalent, treatment options are limited and the benign course of DPNs may cause them to be overlooked by clinicians. However, large a …
Item in Clipboard
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.
Seirafianpour F, Sodagar S, Pour Mohammad A, Panahi P, Mozafarpoor S, Almasi S, Goodarzi A.
Seirafianpour F, et al.
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
Dermatol Ther. 2020.
PMID: 32639077
Free PMC article.
It could be manifest most commonly as a maculopapular exanthamatous or morbiliform eruption, generalized urticaria or pseudo chilblains recognized as "COVID toes" (pernio-like acral lesions or vasculopathic rashes). During pandemic, Non-infected non-at risk patients with i …
It could be manifest most commonly as a maculopapular exanthamatous or morbiliform eruption, generalized urticaria or pseudo chilblains reco …
Item in Clipboard
A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations.
Salehi S, Sadeghi S, Kalantari Y, Goodarzi A.
Salehi S, et al.
Am J Dermatopathol. 2023 Jan 1;45(1):1-27. doi: 10.1097/DAD.0000000000002320. Epub 2022 Nov 7.
Am J Dermatopathol. 2023.
PMID: 36484603
Eruptions that underwent a biopsy were mostly described as erythematous maculopapular, papulosquamous, vasculitis-like, lichenoid, or urticarial lesions. Histopathology revealed spongiosis, interstitial, and perivascular lymphohistiocytic infiltration, erythrocyte e …
Eruptions that underwent a biopsy were mostly described as erythematous maculopapular, papulosquamous, vasculitis-like, lichenoid, or …
Item in Clipboard
Cite
Cite